- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02712294
Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension
Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension
Pulmonary hypertension (PH) features symptoms related to a decreased cardiac autonomic response, pulmonary function and exercise capacity.
Non-pharmacological interventions are low cost and can significant enhance outcomes in these patients. Neuromuscular electrical stimulation (NMES) has been proposed as a viable therapeutic approach in patients with functional limitations, particularly those that present with difficulty to perform exercise protocols.
Objective: to evaluate the impact of NMES on exercise capacity, spirometry values and quality of life of patients with PH.
Material and methods: prospective randomized controlled study with a control group (GC, n9) and NMES goup (GE, n8). Quality of life and exercise capacity through the six-minute walk test (6MWT) were assessed before and after the NMES protocol.
Results: the GE presented with a significant improvement in distance walked in the 6MWT, cycle ergometry, spirometry and quality of life in the areas of vitality, emotional and social aspects of the questionnaire Short Form Health Survey-36.
Conclusion: NMES is a useful tool in the treatment of patients with PH, resulting in improved exercise capacity, quality of life and lung function testing.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Sao Paulo, Brasilien, 01221-020
- Santa Casa of Sao Paulo Medical School
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Males and females greater than or equal to 18 years of age, clinically stable with optimized drug therapy in the last 3 months, previously diagnosed with a mean pulmonary arterial pressure ≥ 25 mmHg by right heart catheterization and who agreed to participate by signing an informed consent were included.
Exclusion Criteria:
Exclusion criteria included a diagnosis of Down syndrome, orthopedic disease or neurologic or diagnoses, history of acute heart attack, use of beta-blockers, any urgent or elective surgical intervention during the implementation of the protocol, those who used assistive devices to ambulate or develop an infectious process during the study protocol.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Control Group (GC)
The GC received standard ambulatory care, including routine exams and drug therapy.
All patients were reassessed after the 2 month protocol.
|
|
|
Eksperimentel: NMES Group (GE)
Receiving the usual care and guidance on their illness, underwent 30 minute NMES sessions twice a week for two months using an electrostimulator.
Specifically, 5 cm adhesive surface electrodes in four alternate channels on the Rectus Femoris (two channels the right and two on the left) were used to deliver two-phase symmetrical currents, with a rectangular pulse wave at a frequency of 35 Hz and pulse duration of 250 μ.
The time of ascent and descent was one second, contraction time was four seconds and relaxation was eight seconds.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Distance in six-minute walk test
Tidsramme: change from baseline in distance at 2 months
|
analysis of distance
|
change from baseline in distance at 2 months
|
|
Oxygen saturation in six-minute walk test
Tidsramme: change from baseline in oxygen saturation at 2 months
|
analysis of oxygen saturation at end of test
|
change from baseline in oxygen saturation at 2 months
|
|
Systolic blood pressure in six-minute walk test
Tidsramme: change from baseline in systolic blood pressure at 2 months
|
analysis of systolic blood pressure at end of test
|
change from baseline in systolic blood pressure at 2 months
|
|
Diastolic blood pressure in six-minute walk test
Tidsramme: change from baseline in diastolic blood pressure at 2 months
|
analysis of diastolic blood pressure at end of test
|
change from baseline in diastolic blood pressure at 2 months
|
|
Heart rate in six-minute walk test
Tidsramme: change from baseline in heart rate at 2 months
|
analysis of heart rate at end of test
|
change from baseline in heart rate at 2 months
|
|
Borg scale in six-minute walk test
Tidsramme: change from baseline in Borg scale at 2 months
|
analysis of Borg scale at end of test
|
change from baseline in Borg scale at 2 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The Medical Outcomes Study 36-item Short Form Health Survey
Tidsramme: change from baseline at 2 months
|
The questionnaire covers 36 items, designed to assess health concepts
|
change from baseline at 2 months
|
|
Forced vital capacity
Tidsramme: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Forced expiratory volume in the first second
Tidsramme: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Forced expiratory flow 25-75 %
Tidsramme: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Ratio of forced expiratory volume in the first second and forced vital capacity
Tidsramme: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Parece 517.472
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Pulmonal hypertension
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Inhibikase TherapeuticsIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien
-
University Hospital, BrestIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Frankrig
-
Shanghai Zhongshan HospitalIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
Kliniske forsøg med Neuromuskulær elektrisk stimulering
-
University Hospital MuensterUkendtSlag | Dysfagi | EkstubationsfejlTyskland
-
Phagenesis Ltd.NAMSA; Cytel Inc.AfsluttetDysfagiØstrig, Tyskland, Schweiz
-
Imperial College LondonAfsluttet
-
Peking Union Medical College HospitalUkendtPrimiparous kvinder med singleton baby ved terminKina
-
Nu Eyne Co., Ltd.AfsluttetTør øjensygdomKorea, Republikken
-
Oregon Health and Science UniversityAfsluttet
-
Medtronic Corporate Technologies and New VenturesAfsluttet
-
Medical College of WisconsinChildren's Wisconsin; Advancing a Healthier Wisconsin Endowment (AHW)AfsluttetParoksysmal sympatisk hyperaktivitetForenede Stater
-
University of MiamiFloridaAfsluttetNeuropatisk smerteForenede Stater
-
US Department of Veterans AffairsAfsluttetKardiovaskulær sygdom | RygmarvsskadeForenede Stater